ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Summary

This is a multicenter, single-arm study for safety and efficacy.

Timeline

Start

2010-02-02

Primary completion

2011-11-30

Completion

2011-11-30

Outcome

Outcome not reported

Stopped: “The study was terminated early for futility according to the stopping rule of the Simon 2-stage design.”

Drugs

Indications